top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

RIGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.43%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Rigel Pharmaceuticals Insider Trading History Chart

Rigel Pharmaceuticals Share Price & Price History

^$1.13

▼ -0.01 (-0.88%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Rigel Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/2/2023	David A Santos	EVP	Sell	5,388	$1.66	$8,944.08	144,612
2/2/2023	Dean L Schorno	CFO	Sell	5,389	$1.66	$8,945.74	196,519
6/9/2022	Raul R Rodriguez	CEO	Buy	1,000,000	$0.69	$690,000.00	1,391,776

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for Rigel Pharmaceuticals (NASDAQ:RIGL)

66.23% of Rigel Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Rigel Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/5/2024	Los Angeles Capital Management LLC	603,123	$0.89M	0.0%	+49.1%	0.344%
2/13/2024	Armistice Capital LLC	17,100,000	$24.80M	0.3%	-0.2%	9.807%
2/5/2024	Russell Investments Group Ltd.	145,559	$0.21M	0.0%	-24.7%	0.083%
1/17/2024	Assenagon Asset Management S.A.	1,991,398	$2.89M	0.0%	-28.1%	1.142%
1/12/2024	SG Americas Securities LLC	49,673	$72K	0.0%	+57.7%	0.028%
11/17/2023	Jacobs Levy Equity Management Inc.	3,369,076	$3.64M	0.0%	-5.7%	1.932%
11/15/2023	GSA Capital Partners LLP	971,441	$1.05M	0.1%	+170.9%	0.557%
11/15/2023	Armistice Capital LLC	17,136,000	$18.51M	0.3%	+0.2%	9.827%
11/13/2023	Acadian Asset Management LLC	4,660,740	$5.03M	0.0%	+1.7%	2.673%
11/6/2023	Assenagon Asset Management S.A.	2,769,841	$2.99M	0.0%	-23.6%	1.589%
11/2/2023	Principal Financial Group Inc.	121,938	$0.13M	0.0%	+22.0%	0.070%
10/27/2023	Allspring Global Investments Holdings LLC	105,067	$0.11M	0.0%	+28.9%	0.060%
10/13/2023	SG Americas Securities LLC	31,493	$34K	0.0%	N/A	0.018%
9/21/2023	Barclays PLC	45,496	$59K	0.0%	-53.9%	0.026%
8/15/2023	Sphera Funds Management LTD.	1,228,126	$1.58M	0.2%	-34.6%	0.704%
8/14/2023	Graham Capital Management L.P.	81,705	$0.11M	0.0%	+622.5%	0.047%
8/11/2023	Natixis	57,246	$74K	0.0%	N/A	0.033%
8/11/2023	Visionary Wealth Advisors	22,297	$29K	0.0%	+64.8%	0.013%
8/11/2023	Rhenman & Partners Asset Management AB	253,832	$0.33M	0.0%	-78.1%	0.146%
8/10/2023	Tamarack Advisers LP	1,250,000	$1.61M	0.5%	-37.5%	0.717%
8/7/2023	Principal Financial Group Inc.	99,976	$0.13M	0.0%	-13.0%	0.057%
8/7/2023	Acadian Asset Management LLC	4,581,512	$5.91M	0.0%	+23.0%	2.628%
8/3/2023	Los Angeles Capital Management LLC	403,466	$0.52M	0.0%	+3.7%	0.232%
7/31/2023	Strs Ohio	177,000	$0.23M	0.0%	+8.5%	0.102%
7/27/2023	Virtu Financial LLC	50,288	$65K	0.0%	N/A	0.029%
7/25/2023	Assenagon Asset Management S.A.	3,624,538	$4.68M	0.0%	+177.3%	2.087%
7/24/2023	Vontobel Holding Ltd.	30,000	$39K	0.0%	N/A	0.017%
5/16/2023	Armistice Capital LLC	17,024,000	$22.47M	0.3%	+0.4%	9.803%
5/12/2023	Rhenman & Partners Asset Management AB	1,157,593	$1.55M	0.2%	-5.5%	0.667%
5/11/2023	Acadian Asset Management LLC	3,723,563	$4.91M	0.0%	+5.1%	2.144%
5/11/2023	Tamarack Advisers LP	2,000,000	$2.64M	1.0%	-13.0%	1.152%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	583,393	$0.77M	0.0%	+1.9%	0.336%
5/9/2023	Russell Investments Group Ltd.	211,579	$0.28M	0.0%	+35.9%	0.122%
5/4/2023	Los Angeles Capital Management LLC	389,132	$0.51M	0.0%	-3.1%	0.224%
4/28/2023	SG Americas Securities LLC	149,771	$0.20M	0.0%	N/A	0.086%
4/18/2023	Connecticut Wealth Management LLC	115,200	$0.15M	0.0%	+44.0%	0.066%
4/18/2023	Assenagon Asset Management S.A.	1,307,288	$1.73M	0.0%	+58.5%	0.753%
4/13/2023	Allspring Global Investments Holdings LLC	88,385	$0.12M	0.0%	+26.4%	0.051%
3/23/2023	MetLife Investment Management LLC	64,805	$97K	0.0%	-32.0%	0.037%
2/28/2023	Voya Investment Management LLC	2,998,491	$4.50M	0.0%	-16.7%	1.735%
2/15/2023	Armistice Capital LLC	16,956,000	$25.43M	0.4%	+391.1%	9.810%
2/13/2023	Tamarack Advisers LP	2,300,000	$3.45M	1.8%	+15.0%	1.331%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	572,791	$0.86M	0.0%	N/A	0.331%
2/10/2023	HRT Financial LP	181,355	$0.27M	0.0%	-83.3%	0.105%
2/9/2023	CM Management LLC	1,500,000	$2.25M	2.7%	+15.4%	0.868%
2/9/2023	Principal Financial Group Inc.	132,567	$0.20M	0.0%	+195.0%	0.077%
2/8/2023	Russell Investments Group Ltd.	155,689	$0.23M	0.0%	+4.2%	0.090%
2/6/2023	Los Angeles Capital Management LLC	401,589	$0.60M	0.0%	+42.3%	0.232%
2/2/2023	ProShare Advisors LLC	22,205	$33K	0.0%	-33.8%	0.013%
1/23/2023	Allspring Global Investments Holdings LLC	69,925	$0.11M	0.0%	+100.2%	0.040%
1/17/2023	Diversified Trust Co	31,538	$47K	0.0%	+109.2%	0.018%
1/13/2023	Dynamic Advisor Solutions LLC	22,800	$34K	0.0%	+39.9%	0.013%
1/12/2023	Assenagon Asset Management S.A.	824,858	$1.24M	0.0%	-69.2%	0.477%
11/17/2022	Telemetry Investments L.L.C.	200,000	$0.24M	0.3%	-13.0%	0.116%
11/15/2022	Jacobs Levy Equity Management Inc.	2,960,001	$3.49M	0.0%	N/A	1.713%
11/15/2022	Bayesian Capital Management LP	20,945	$25K	0.0%	N/A	0.012%
11/14/2022	Armistice Capital LLC	3,452,874	$4.07M	0.1%	N/A	1.998%
11/14/2022	Point72 Hong Kong Ltd	42,212	$50K	0.0%	N/A	0.024%
11/14/2022	Lazard Asset Management LLC	41,408	$48K	0.0%	N/A	0.024%
11/14/2022	UBS Oconnor LLC	286,139	$0.34M	0.0%	-33.6%	0.166%
11/14/2022	MetLife Investment Management LLC	95,364	$0.11M	0.0%	+1,135.8%	0.055%
11/10/2022	ExodusPoint Capital Management LP	353,244	$0.42M	0.0%	N/A	0.204%
11/7/2022	Jump Financial LLC	114,938	$0.14M	0.0%	N/A	0.067%
11/4/2022	Prudential Financial Inc.	189,857	$0.22M	0.0%	+1,557.1%	0.110%
11/4/2022	Russell Investments Group Ltd.	149,465	$0.18M	0.0%	+1,605.2%	0.086%
11/3/2022	Teacher Retirement System of Texas	56,347	$66K	0.0%	+106.9%	0.033%
11/2/2022	Los Angeles Capital Management LLC	282,239	$0.33M	0.0%	+15.5%	0.163%
11/1/2022	Great West Life Assurance Co. Can	79,230	$93K	0.0%	+793.5%	0.046%
10/31/2022	SG Americas Securities LLC	102,058	$0.12M	0.0%	-48.5%	0.059%
10/27/2022	Assenagon Asset Management S.A.	2,679,850	$3.16M	0.0%	+61.5%	1.550%
10/26/2022	Allspring Global Investments Holdings LLC	34,936	$41K	0.0%	+111.5%	0.020%
8/16/2022	Tamarack Advisers LP	2,000,000	$2.26M	1.3%	-38.5%	1.157%
8/16/2022	Woodline Partners LP	861,305	$0.97M	0.0%	+4.6%	0.498%
8/16/2022	DAFNA Capital Management LLC	390,066	$0.44M	0.1%	-56.5%	0.226%
8/13/2022	Virtu Financial LLC	245,227	$0.28M	0.0%	N/A	0.142%
8/12/2022	Ikarian Capital LLC	702,773	$0.79M	0.1%	-67.1%	0.407%
8/12/2022	Rafferty Asset Management LLC	1,088,543	$1.23M	0.0%	+212.6%	0.630%
8/11/2022	Alps Advisors Inc.	102,065	$0.12M	0.0%	-42.2%	0.059%
8/10/2022	Mackenzie Financial Corp	34,933	$39K	0.0%	+74.9%	0.020%
8/8/2022	Oppenheimer & Co. Inc.	42,587	$48K	0.0%	-20.0%	0.025%
8/8/2022	CM Management LLC	1,300,000	$1.47M	1.6%	+67.7%	0.752%
8/1/2022	ProShare Advisors LLC	32,785	$37K	0.0%	-34.1%	0.019%
7/29/2022	SG Americas Securities LLC	198,210	$0.22M	0.0%	N/A	0.115%
7/27/2022	Assenagon Asset Management S.A.	1,659,746	$1.88M	0.0%	+120.4%	0.965%
7/25/2022	Strs Ohio	163,200	$0.18M	0.0%	+6.0%	0.095%
5/27/2022	Walleye Capital LLC	1,049,059	$3.14M	0.1%	+43.8%	0.610%
5/17/2022	Rock Springs Capital Management LP	4,921,487	$14.72M	0.4%	+1.3%	2.860%
5/17/2022	Great Point Partners LLC	4,000,000	$11.96M	2.9%	-20.0%	2.325%
5/16/2022	J. Goldman & Co LP	529,905	$1.58M	0.1%	+176.2%	0.308%
5/12/2022	Acadian Asset Management LLC	812,793	$2.43M	0.0%	+38.9%	0.472%
5/11/2022	Tamarack Advisers LP	3,250,000	$9.72M	4.6%	-27.8%	1.889%
5/9/2022	Qube Research & Technologies Ltd	112,005	$0.34M	0.0%	+8.9%	0.065%
5/5/2022	Russell Investments Group Ltd.	91,221	$0.27M	0.0%	+14.6%	0.053%
4/27/2022	Dupont Capital Management Corp	61,175	$0.18M	0.0%	-8.1%	0.036%
4/26/2022	Sciencast Management LP	15,681	$49K	0.0%	N/A	0.009%
4/25/2022	Assenagon Asset Management S.A.	753,110	$2.25M	0.0%	N/A	0.438%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	26,693	$80K	0.0%	-37.1%	0.016%
4/18/2022	Connecticut Wealth Management LLC	80,000	$0.24M	0.0%	N/A	0.047%
4/6/2022	First Hawaiian Bank	163,484	$0.49M	0.0%	-10.3%	0.095%
3/3/2022	Walleye Capital LLC	729,297	$1.93M	0.0%	N/A	0.426%

Data available starting January 2016

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer, as well as for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral IRAK1/4 Inhibitor, which is in Phase 1b clinical trials for the treatment of hematology-oncology, autoimmune, and inflammatory diseases; and a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor program in clinical development with partner Eli Lilly and Company. In addition, the company has product candidates in clinical development with partners BerGenBio ASA and Daiichi Sankyo. The company has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of REZLIDHIA (Olutasidenib) in acute myeloid leukemia (AML) and other hematologic cancers. The company was incorporated in 1996 and is headquartered in South San Francisco, California.

Today's Range

Now: $1.13

$1.11

$1.16

50 Day Range

MA: $1.33

$1.05

$1.57

52 Week Range

Now: $1.13

$0.71

$1.96

Volume

6,448,270 shs

Average Volume

1,321,567 shs

Market Capitalization

$197.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Rigel Pharmaceuticals?: Rigel Pharmaceuticals' top insider shareholders include:
Raul R Rodriguez (CEO)
Dean L Schorno (CFO)
David A Santos (EVP)
Learn More about top insider investors at Rigel Pharmaceuticals.
Who are the major institutional investors of Rigel Pharmaceuticals?: Rigel Pharmaceuticals' top institutional shareholders include:
Los Angeles Capital Management LLC — 0.34%
Learn More about top institutional investors of Rigel Pharmaceuticals stock.
Which major investors are buying Rigel Pharmaceuticals stock?: In the previous quarter, RIGL stock was purchased by institutional investors including:
Los Angeles Capital Management LLC

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

RIGL Insider Trading

Rigel Pharmaceuticals Insider Trading History Chart

Rigel Pharmaceuticals Share Price & Price History

Rigel Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Rigel Pharmaceuticals (NASDAQ:RIGL)

Institutional Buying and Selling by Quarter

Rigel Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Rigel Pharmaceuticals?

Who are the major institutional investors of Rigel Pharmaceuticals?

Which major investors are buying Rigel Pharmaceuticals stock?